Profiel
Mr. Jamal El-Mosleh is a Chief Executive Officer at Elicera Therapeutics AB. Mr. El-Mosleh was previously employed as a Chief Executive Officer by Annexin Pharmaceuticals AB and a Chief Executive Officer & IR Contact by Immunicum AB. He also served on the board at Elypta AB. He received his graduate degree from Chalmers University of Technology and a graduate degree from Chalmers School of Entrepreneurship.
Actieve functies van Jamal El-Mosleh
| Bedrijven | Functie | Begin |
|---|---|---|
| ELICERA THERAPEUTICS AB | Algemeen Directeur | 01-01-2020 |
Eerdere bekende functies van Jamal El-Mosleh
| Bedrijven | Functie | Einde |
|---|---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Directeur/Bestuurslid | 01-01-2020 |
| ANNEXIN PHARMACEUTICALS AB | Algemeen Directeur | 01-01-2019 |
| MENDUS AB | Algemeen Directeur | 01-10-2016 |
Opleiding van Jamal El-Mosleh
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Chalmers School of Entrepreneurship
Chalmers School of Entrepreneurship Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Annexin Pharmaceuticals AB
Annexin Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures drugs for cardiovascular diseases | Health Technology |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Technology Services |
Elicera Therapeutics AB
Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
















